Fungal infections affect over a billion people, with mortality rates estimated at 1-2 million per year [1] [2] [3] . Advances in modern medicine, such as solid organ and bone marrow transplants, or anti-neoplasic chemotherapy, and the AIDS pandemic are associated with the dramatic increases of opportunistic fungal infections [1, [4] [5] [6] . However, antifungal options for the treatment systemic fungal diseases are still limited [3] . To investigate the fungal-host interactions and to discover new antifungal agents, it is essential to use a variety of in vivo models [7, 8] . Over the last decade, it has become clear that non-mammalian model hosts can be very useful for validating in vitro results and to test hypotheses that could be translated into higher organisms and clinical studies [9] [10] [11] . In this special issue, invertebrate, zebrafish, and amoeboid models are carefully discussed to provide an update on recent advances and a reflection on future directions.
as by monitoring the immune response associated with the infection process [15] . In this context, Kavanagh and Sheehan [15] explore the use of the G. mellonella model for the study of antifungal treatments. Many topics are discussed in this article, such as the assays to test relative toxicity in vivo, to identify the optimum combinations of antifungal drugs for resistant microorganisms, to study the mode of action of different classes of compounds, and to establish dosages prior to use in mammals. In another article, Cruz et al. [16] show inedited results of their research with four thiazolylhdrazone derivatives. The compounds tested demonstrated low toxicity, were able to prolong the survival of G. mellonella larvae infected with C. albicans, and reached the same efficacy as fluconazole. Among them, compound 2 (2-((2-(hexan-3-ylidene) hydrazino)-4-(4-methoxyphenyl)-thiazole) showed the most promising results and was identified as a potential candidate for further studies in murine models.
The G. mellonella model has been widely adopted by many researchers around the world [17] [18] [19] [20] [21] [22] . However, the lack of standardization of larvae quality impairs the reproducibility and comparison of data between laboratories [17, 23, 24] . In this special issue, Champion et al. [23] raise an interesting discussion about the factors that need to be considered during the handling of G. mellonella for research, including age, size, availability of food, reared techniques, physical stress to transportation, incubation temperature, storage time, and possible residual levels of antibiotics and hormones. The authors suggest solutions on how to address these issues such as the pathological scoring system using automated real-time imaging, and developing of a standard well-characterized G. mellonella strain for research. While research and standardized procedures advance rapidly to make G. mellonella a robust and consistent infection model [23] , other insect models can also be explored. For example, Souza et al. [25] present Tenebrio molitor (mealworm) as a potential model for the study of pathogenic fungi. This insect host has similar characteristics to G. mellonella, however its breeding in laboratory conditions is less laborious. These authors outline the first studies with T. molitor involving C. albicans, C. neoformans, Malassezia furfur and Fonsecaea pedrosi, and discuss the advantages of this model for the study of fungal virulence, mycotoxin effects, host immune responses, and the efficacy of antifungal agents.
In addition to insect model hosts, the nematode Caenorhabditis elegans is approached by Elkabti et al. [26] who describe the recent advances of this model to study Candida spp. infections. A great focus is given to the development of new visualization techniques to enhance capturing infection processes within live worms, tracking of nematodes, and the automation of high throughput assays. Other interesting topics are also discussed, such as the recent studies on the microbiome of C. elegans in nature, and the use of this model to identify molecular mechanisms involved in the development of drug resistance. In another article, Rosowski et al. [27] present an extensive review on the zebrafish model, a vertebrate animal. These authors emphasize the unique advantages of this model for the study of host-pathogen interactions. The zebrafish model offers multiple routes for infection with the possibility to monitor the infection process through the whole-body and at different localizations. In this way, recent advances on the development of live imaging platforms are discussed, such as light sheet fluorescence microscopy (LSFM) and correlative light and electron microscopy (CLEM).
To complete this special issue, Casadevall et al. raise important aspects in relation to Acanthamoeba spp., a free-living protozoa also used as a model host for fungal pathogens [28] . The article highlights the correlation of virulence factors between animal models and amoeba, and discusses the concept that animal pathogenic fungi acquire many of their virulence characteristics from interactions with environmental predators, such as soli amoeboid. Amoeba predation can be also associated with metabolic changes that reduce fungal susceptibility to polyenes. The authors highlight the importance to consider that mammals are only a small fraction of any environmental niche, and that many virulence attributes are a result of fungal interactions with other hosts.
Overall this special issue highlights the consensus regarding the alternative model hosts, such as amoebae, insects, worms, and zebrafish that are valuable and reliable tools to study fungal pathogenesis, but there are still several challenges and unexplored fields to be conquered.
